Market Insights

Moderate AS patients outnumbered severe AS by nearly 2:1

Moderate Aortic Stenosis (AS) With At-Risk Features

ACTIVATE AS is a prospective, multicenter observational study using the CardioCare® platform to identify and follow patients with moderate AS. Participants receive heart team evaluation, core lab echo, natriuretic peptide testing and CT calcium scoring. Enrollment is expected to begin in 2027.

Read More »
"The future of aortic stenosis care requires proactive identification, longitudinal monitoring, and intentional pipeline management."

Rethinking the Aortic Stenosis Pipeline

Aortic stenosis care is shifting from a reactive to a proactive model. Emerging clinical evidence supports earlier identification, closer monitoring, and intentional patient management across the disease continuum. As treatment thresholds evolve, health systems need scalable approaches to identify at-risk patients, close treatment gaps, and ensure timely access to specialist

Read More »

Cath Lab Capacity is Up—But Structural Heart Procedures Are Being Outpaced by Other Interventions

Heart failure with a preserved ejection fraction (HFpEF) accounts for more than half of all heart failure cases and carries significant morbidity and mortality risk, especially after hospitalization1. Historically, management of the disease is largely focused on comorbidity management and lifestyle modifications, given that available therapies had not demonstrated sufficient

Read More »

egnite Registry

Power Your Research with the egnite Registry

Longitudinal clinical data designed for advanced real-world research